Home
Sign In
About
Curriculum
Activity Information
Target Audience
Learning Objectives
Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
Course materials have been developed for use outside of the United States.
|
 |
|
|
|
|
|
Iron Overload Case Library II, Case 1: Managing Iron Overload in a Patient with Transfusion-Independent Thalassaemia Intermedia
Join Dr. Ali T. Taher for this case study as he follows a patient with nontransfused thalassaemia intermedia. The decision points reflect the need for clinical judgment in anticipating iron overload despite the absence of transfusion, interpreting discordant serum ferritin levels and liver iron concentration, and responding to noncompliance to chelation therapy.
|
|
Faculty
|
|
|
Ali T. Taher, MD
Professor
Department of Internal Medicine
American University of Beirut Medical Center
Beirut, Lebanon
|
|
|
Target Audience
This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.
|
Learning Objectives
After participating in this activity, participants should be better able to:
- Evaluate the potential role of iron chelation in managing iron overload in transfusion-independent thalassaemia intermedia.
|
Disclosure Information
Ali T. Taher, MD, is on the speakers bureau of and on the advisory board for Novartis Pharmaceuticals Corporation. Dr. Taher has disclosed that he will discuss the use of deferasirox for the treatment of chronic iron overload in patients with thalassamia intermedia, which is not approved by the EMEA.
|
|
|
|
|
|
|
